Rifampicin-induced immune allergic reaction-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rifampicin-induced immune allergic reaction

Published:2017-08 Issue:2 Volume:48 Page:156-159
ISSN:0049-4755
Container-title:Tropical Doctor
language:en
Short-container-title:Trop Doct

Author:

Sadanshiv Mahima¹,George Anu Anna²,Mishra Ajay Kumar³,Kuriakose Cijoy K⁴

Affiliation:

1. Resident, Department of Internal Medicine, Christian Medical College and Hospital, Vellore, Tamil Nadu, India

2. Assistant Professor, Department of Dermatology, Christian Medical College and Hospital, Vellore, Tamil Nadu, India

3. Assistant Professor, Department of Internal Medicine, Christian Medical College and Hospital, Vellore, Tamil Nadu, India

4. Lecturer, Department of Internal Medicine, Christian Medical College and Hospital, Vellore, Tamil Nadu, India

Publisher

SAGE Publications

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Link

http://journals.sagepub.com/doi/pdf/10.1177/0049475517724689

Reference11 articles.

1. History of the Development of Rifampin

2. Treatment of tuberculosis and optimal dosing schedules

3. Directly observed therapy for tuberculosis: history of an idea

4. Recurrent Disseminated Intravascular Coagulation Caused by Intermittent Dosing of Rifampin

5. Evidence Implicating Rifampin-Independent Antiplatelet Antibodies in the Pathogenesis of Rifampin-Induced Immune Thrombocytopenia

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coinfections with COVID-19: A focus on tuberculosis (TB);Management, Body Systems, and Case Studies in COVID-19;2024

2. Syndrome pseudogrippal avec choc induit par la rifampicine chez une patiente atteinte d’infection tuberculeuse;Canadian Medical Association Journal;2023-11-05

3. Rifampin-induced flu-like syndrome with shock in a patient with tuberculosis infection;Canadian Medical Association Journal;2023-09-04

4. COVID-19 and Tuberculosis: Unveiling the Dual Threat and Shared Solutions Perspective;Journal of Clinical Medicine;2023-07-19

5. Pathogenesis of SARS-CoV-2 and Mycobacterium tuberculosis Coinfection;Frontiers in Immunology;2022-06-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3